Speakers

Dr Ulrich Rose

Dr Ulrich Rose

Straßburg

Dr René Roth-Ehrang

Dr René Roth-Ehrang

Finzelberg

Dr Evelyn Wolfram

Dr Evelyn Wolfram

Zurich University of Applied Sciences

Dr Henrik Harms

Dr Henrik Harms

BfArM

Dr Nikos Xynos

Dr Nikos Xynos

Nomad Labs Scientific

Philip Junker Andersen

Philip Junker Andersen

IntuBio

Joaquin Dell’Acqua

Joaquin Dell’Acqua

Agronomist

Dr Gerlinde Kugler

Dr Gerlinde Kugler

Austrian Agency for Health and Food Safety (AGES)

Note: All times mentioned are CEST.

Objectives

The course will provide you with the necessary GMP/GACP knowledge for Herbal Drugs, Herbal Drug Preparations (e.g. Extracts) and Herbal Medicinal Products (HMPs). This includes regulatory & quality requirements as well as applicable pharmacopoeial monographs and challenges often encountered in HMPs, e.g. during stability studies.

Background

Herbal Medicinal Products are accepted and widely-used remedies. Although several routes exist for HMPs to receive a marketing authorization, e.g. well-established or traditional use – or special cases like medical cannabis as “Formula magistralis / officinalis” without marketing authorization - they all need to fulfill the same pharmaceutical quality standards. However, HMPs have some very specific characteristics that must be taken into consideration for GMP compliant production, quality control, release and stability testing. Questions often raised include the following:
  • Which contaminants have to be considered?
  • Which microbiological provisions apply?
  • Which kind of decontamination procedures can be used?
  • Are there different requirements for herbal drugs, herbal drug preparations (like extracts) and the final HMP?
To provide more detailed information on these requirements, the European Medicines Agency (EMA) recently published the final guidelines (Revision 3) on quality and specifications for herbal medicinal products (HMPs). Amongst others, a written GACP confirmation for the herbal substance should be provided either by the herbal drug supplier or the manufacturer of the active substance / the HMP. In addition, EMA´s HMPC is currently working on the revision of the GACP guideline and recently already published a draft paper.

Target Group

This course is designed for all people in pharmaceutical and API industry’s quality control, regulatory affairs, pharmacovigilance, production and purchasing departments who need to establish, monitor and/or manage the quality of Herbal Drugs / Herbal Medicinal Products.

Date & Technical Requirements

Date 08/09 October 2025
Wednesday, 8 October 2025, 9.00 to approx. 17.30 h (CEST)
Thursday, 9 October 2025, 9.00 to approx. 13.00 h (CEST)
 
Technical Requirements
We use Webex for our live online training courses and webinars. At www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.

Programme

GMP for Herbal Medicinal Products (HMPs) - Live Online Conference

Seminar Programme as PDF

Programme - 8 October 2025
 
Do Phytopharmaceuticals have a Future?
  • Regulatory hurdles and growing competition with dietary supplements 
  • Challenges in the Lifecycle management of herbal medicines
  • How a modernization of EU regulations could help
  • Health claims Issues
Quality Requirements for Marketing Authorization Applications
  • Borderline GACP-GMP
  • Types of extracts
  • Control strategy for extracts and drug products
  • Context with clinical data and regulatory pathway
  • Is a complete dossier always required?
Quality Control and Stability Testing:  Specific Aspects for HMPs
  • Stability testing, in-use stability vs on-going stability
  • Re-test period, Shelf life and storage conditions
  • Focus on herbal substances / preparations / medicinal products
  • Bracketing and Matrixing
Q&A Session 1
 
Herbal Drugs & Herbal Drug Preparations in the European Pharmacopoeia (Ph. Eur.)
  • General / Individual Monographs & General Texts
  • Pyrrolizidine Alkaloids (PAs)
  • Alternatives for Assays
  • Outlook
Herbal Reference Standards (HRS)
  • Pharmacopoeial definition (Ph. Eur.)
  • Different types of HRS
  • Active and analytical markers
GMP and Technology Considerations for Extraction and Purification of Herbal Active Compounds
  • Processes and Methods
  • Different extraction, refining and purification Technologies
  • Key considerations for GMP compliance in integrated processes and Technologies
  • Environmental impact, cost efficiency, and operational aspects
Q&A Session 2
 
 
Programme - 9 October 2025
 
From Field to Facility: Lessons from Annex 7 vs GACP and Inspections
  • Regulatory Aspects
  • Quality management System (QMS)
  • Quality Risk Management (QRM)
  • Points to consider
Cultivation under GACP
  • Cultivation and the implementation of GACP Standards
  • Practical insights
  • Case studies
Requirements & Challenges for the Microbiological Testing of HMPs
  • Typical microflora of medicinal plants
  • Requirements for the microbiological quality of herbal medicinal products
  • Microbiological test methods and proof of suitability
  • Decontamination methods for herbal starting materials
  • Experiences from authority inspections
Final Discussion

ECA-Member*: € 1890,-
Non ECA Member*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025